Search research articles
Contact Us
Filters
Showing results (121-130 of 206) with videos related to
Page
of 21
Sort By:
Clinical Epigenetics
|
January 9, 2019
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents
Riccardo Ricci, Maurizio Martini, Gloria Ravegnini, et al.
Integrative Cancer Therapies
|
May 7, 2019
A Pilot Low-Inflammatory Dietary Intervention to Reduce Inflammation and Improve Quality of Life in Patients With Familial Adenomatous Polyposis: Protocol Description and Preliminary Results
Patrizia Pasanisi, Manuela Gariboldi, Paolo Verderio, et al.
Histopathology
|
June 6, 2014
Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation
Massimo Milione, Patrizia Gasparini, Gabriella Sozzi, et al.
Biomedicines
|
July 29, 2023
A2AR Expression and Immunosuppressive Environment Independent of <i>KRAS</i> and <i>GNAS</i> Mutations in Pseudomyxoma Peritonei
Shigeki Kusamura, Adele Busico, Elena Conca, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 22, 2021
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based Treatments
Cristina Borzi, Monica Ganzinelli, Elisa Caiola, et al.
Journal of Clinical Medicine
|
April 30, 2021
Myeloid and T-Cell Microenvironment Immune Features Identify Two Prognostic Sub-Groups in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms
Giovanni Centonze, Vincenzo Lagano, Giovanna Sabella, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 25, 2017
MIF/CD74 axis is a target for novel therapies in colon carcinomatosis
Fabio Bozzi, Angela Mogavero, Luca Varinelli, et al.
The Journal of Pathology. Clinical Research
|
May 29, 2019
Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms
Massimo Milione, Rosalba Miceli, Francesco Barretta, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 2, 2024
Colorectal carcinoma peritoneal metastases-derived organoids: results and perspective of a model for tailoring hyperthermic intraperitoneal chemotherapy from bench-to-bedside
Luca Varinelli, Davide Battistessa, Marcello Guaglio, et al.
The Oncologist
|
January 22, 2026
Everolimus as maintenance therapy in advanced neuroendocrine neoplasms: Results from the MAVERIC Phase II Trial (1499 WORDS MAIN TEXT)
Lorenzo Antonuzzo, Daniele Lavacchi, Francesca Spada, et al.
Page
of 21
Search research articles
Search
Showing results (121-130 of 206) with videos related to
Sort By:
Page
of 21
Clinical Epigenetics
|
January 9, 2019
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents
Riccardo Ricci, Maurizio Martini, Gloria Ravegnini, et al.
Integrative Cancer Therapies
|
May 7, 2019
A Pilot Low-Inflammatory Dietary Intervention to Reduce Inflammation and Improve Quality of Life in Patients With Familial Adenomatous Polyposis: Protocol Description and Preliminary Results
Patrizia Pasanisi, Manuela Gariboldi, Paolo Verderio, et al.
Histopathology
|
June 6, 2014
Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation
Massimo Milione, Patrizia Gasparini, Gabriella Sozzi, et al.
Biomedicines
|
July 29, 2023
A2AR Expression and Immunosuppressive Environment Independent of <i>KRAS</i> and <i>GNAS</i> Mutations in Pseudomyxoma Peritonei
Shigeki Kusamura, Adele Busico, Elena Conca, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 22, 2021
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based Treatments
Cristina Borzi, Monica Ganzinelli, Elisa Caiola, et al.
Journal of Clinical Medicine
|
April 30, 2021
Myeloid and T-Cell Microenvironment Immune Features Identify Two Prognostic Sub-Groups in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms
Giovanni Centonze, Vincenzo Lagano, Giovanna Sabella, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 25, 2017
MIF/CD74 axis is a target for novel therapies in colon carcinomatosis
Fabio Bozzi, Angela Mogavero, Luca Varinelli, et al.
The Journal of Pathology. Clinical Research
|
May 29, 2019
Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms
Massimo Milione, Rosalba Miceli, Francesco Barretta, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 2, 2024
Colorectal carcinoma peritoneal metastases-derived organoids: results and perspective of a model for tailoring hyperthermic intraperitoneal chemotherapy from bench-to-bedside
Luca Varinelli, Davide Battistessa, Marcello Guaglio, et al.
The Oncologist
|
January 22, 2026
Everolimus as maintenance therapy in advanced neuroendocrine neoplasms: Results from the MAVERIC Phase II Trial (1499 WORDS MAIN TEXT)
Lorenzo Antonuzzo, Daniele Lavacchi, Francesca Spada, et al.
Page
of 21